Asporin expression is highly regulated in human chondrocytes

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 816-823

  Duval, Elise ^a   Bigot, Nicolas ^a   Hervieu, Magalie ^a   Kou, Ikuyo ^b   Leclercq, Sylvain ^a,c   Galéra, Philippe ^a   Boumediene, Karim ^a   Baugé, Catherine ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITY OF TOKYO   (Japan)

^c Saint Martin Private Clinic   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPORIN; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; SCLEROPROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPN GENE; CARTILAGE CELL; CELL CULTURE; CELL DEDIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATOR GENE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THREE DIMENSIONAL IMAGING; TRANSCRIPTION INITIATION SITE; UPREGULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BINDING SITES; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; MIDDLE AGED; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960729234     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00052     Document Type: Article

References (27)

1. Iozzo RV, Murdoch AD. (1996) Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10:598-614.
2. Lorenzo P, et al. (2001) Identification and characterization of asporin: a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. Biol. Chem. 276:12201-11.
3. Henry SP, et al. (2001) Expression pattern and gene characterization of asporin: a newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276:12212-21.
4. Kizawa H, et al. (2005) An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37:138-44.
5. Ikegawa S. (2008) Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr. Med. Chem. 15:724-8.
6. Verdier MP, Seité S, Guntzer K, Pujol JP, Boumédiène K. (2005) Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol. Int. 25:118-24.
7. Baugé C, et al. (2007) Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum. 56:3020-32.
8. Duval, et al. (2009) Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia- inducible factor 1alpha-dependent redifferentiation of chondrocytes. Arthritis Rheum. 60:3038-48.
9. Guo JF, Jourdian GW, MacCallum DK. (1989) Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect. Tissue Res. 19:277-97.
10. Kou I, Nakajima M, Ikegawa S. (2007) Expression and regulation of the osteoarthritis-associated protein asporin. J. Biol. Chem. 282:32193-9.
11. Baugé C, et al. (2008) NFkappaB mediates IL- 1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression. J. Cell Mol. Med. 12:1754-66.
12. Verrecchia F, Rossert J, Mauviel A. (2001) Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J. Invest. Dermatol. 116:755-63.
13. Heegaard AM, Xie Z, Young MF, Nielsen KL. (2004) Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors. J. Cell. Biochem. 93:463-75.
14. Ghayor C, et al. (2001) Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J. Biol. Chem. 276:36881-95.
15. Tsunoda T, Takagi T. (1999) Estimating transcription factor bindability on DNA. Bioinformatics. 15:622-30.
16. Benya PD, Padilla SR, Nimni ME. (1978) Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 15:1313-21.
17. Benya PD, Shaffer JD. (1982) Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 30:215-24.
18. Bonaventure J, et al. (1994) Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp. Cell Res. 212:97-104.
19. Karvonen RL, et al. (1992) Proteoglycans from osteoarthritic human articular cartilage influence type II collagen in vitro fibrillogenesis. Connect. Tissue Res. 27:235-50.
20. Dourado GS, Adams ME, Matyas JR, Huang D. (1996) Expression of biglycan, decorin and fibromodulin in the hypertrophic phase of experimental osteoarthritis. Osteoarthritis Cartilage. 4:187-96.
21. Cs-Szabó G, Melching LI, Roughley PJ, Glant TT. (1997) Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 40:1037-45.
22. Demoor-Fossard M, Redini F, Boittin M, Pujol JP. (1998) Expression of decorin and biglycan by rabbit articular chondrocytes: effects of cytokines and phenotypic modulation. Biochim. Biophys. Acta. 1398:179-91.
23. von den Hoff H, de Koning M, van Kampen J, van der Korst J. (1995) Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture. J. Rheumatol. 22:1520-6.
24. Yamada S, et al. (2006) Regulation of PLAP-1 expression in periodontal ligament cells. J. Dent. Res. 85:447-51.
25. Horton WE Jr, Higginbotham JD, Chandrasekhar S. (1989) Transforming growth factor-beta and fibroblast growth factor act synergistically to inhibit collagen II synthesis through a mechanism involving regulatory DNA sequences. J. Cell Physiol. 141:8-15.
26. Galéra P, et al. (1992) Effect of transforming growth factor-beta 1 (TGF-beta 1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiating process. Exp. Cell Res. 200:379-92.
27. Tasheva ES, Klocke B, Conrad GW. (2004) Analysis of transcriptional regulation of the small leucine rich proteoglycans. Mol. Vis. 10:758-72.